meglumine has been researched along with alpha-Galactosidase A Deficiency in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abdel-Gadir, A; Baig, S; Edwards, NC; Hughes, D; Kozor, R; Lachmann, RH; Lobascio, I; Medina-Menacho, K; Mehta, A; Moon, JC; Murphy, E; Nordin, S; Ramaswami, U; Sado, DM; Steeds, RP | 1 |
Banypersad, SM; Captur, G; Elliott, PM; Flett, AS; Fontana, M; Hughes, D; Lachmann, RH; Maestrini, V; Mehta, A; Moon, JC; Murphy, E; Neubauer, S; Piechnik, SK; Robson, MD; Sado, DM; Treibel, T; White, SK | 1 |
2 other study(ies) available for meglumine and alpha-Galactosidase A Deficiency
Article | Year |
---|---|
Proposed Stages of Myocardial Phenotype Development in Fabry Disease.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Cardiomyopathies; Child; Contrast Media; Disease Progression; Fabry Disease; Female; Humans; Hypertrophy, Left Ventricular; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Myocardium; Organometallic Compounds; Phenotype; Predictive Value of Tests; Prognosis; Prospective Studies; Sex Characteristics; Sex Factors; Sphingolipids; Ventricular Function, Left; Ventricular Remodeling; Young Adult | 2019 |
Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Case-Control Studies; Contrast Media; Diagnosis, Differential; Fabry Disease; Female; Humans; Hypertrophy, Left Ventricular; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Myocardium; Organometallic Compounds; Predictive Value of Tests; Prospective Studies; Risk Factors; Young Adult | 2013 |